Publikationen


LEDGF/p75 Is Required for an Efficient DNA Damage Response. Victoria Liedtke, Christian Schröder, Dirk Roggenbuck, Romano Weiss, Ralf Stohwasser, Peter Schierack, Stefan Rödiger, Lysann Schenk. Int J Mol Sci. 2021 May 30;22(11):5866.

doi: 10.3390/ijms22115866


Knockout of proteolytic key regulators in malignant peripheral nerve sheath tumor cells by CRISPR/Cas9. Meike Rosanski, Lysann Sauer, Christian Schröder, Ralf Stohwasser. Journal of Cellular Biotechnology 2018, vol. 4, no. 1-2, pp. 5-13

doi: 10.3233/JCB-189002


Adhesion of Salmonella to Pancreatic Secretory Granule Membrane Major Glycoprotein GP2 of Human and Porcine Origin Depends on FimH Sequence Variation. Rafal Kolenda, Michał Burdukiewicz, Juliane Schiebel, Stefan Rödiger, Lysann Sauer, Istvan Szabo, Aleksandra Orlowska, Jörg Weinreich, Jörg Nitschke, Alexander Böhm, Ulrike Gerber, Dirk Roggenbuck, Peter Schierack. Front. Microbiol. 2018. Vol. 9

doi: 10.3389/fmicb.2018.01905


Therapeutic potential of targeting SK1 in human cancers. Heba Alshaker, Lysann Sauer, Danielle Monteil, Silvia Ottaviani, Shyam Srivats, Torsten Böhler, Dmitri Pchejetski. Adv Cancer Res. 2013;117:143-200.

doi: 10.1016/B978-0-12-394274-6.00006-6


Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells. L Sauer, D Gitenay, C Vo, V T Baron. Oncogene. 2010 May 6;29(18):2628-37.

doi: 10.1038/onc.2010.24


FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1. Dmitri Pchejetski, Torsten Bohler, Leyre Brizuela, Lysann Sauer, Nicolas Doumerc, Muriel Golzio, Vishal Salunkhe, Justin Teissié, Bernard Malavaud, Jonathan Waxman, Olivier Cuvillier. Cancer Res. 2010 Nov 1;70(21):8651-61.

doi: 10.1158/0008-5472.CAN-10-1388


Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer. Dmitri Pchejetski, Joao Nunes, Lysann Sauer, Jasmin Sidhu, Anand Sharma, Hector C Keun, Jonathan Waxman, Justin Stebbing. Breast Cancer Res Treat. 2010 Nov;124(2):543-9.

doi: 10.1007/s10549-010-0968-y


Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel. Lysann Sauer, Joao Nunes, Vishal Salunkhe, Lenka Skalska, Takafumi Kohama, Olivier Cuvillier, Jonathan Waxman, Dmitry Pchejetski. Int J Cancer. 2009 Dec 1;125(11):2728-36.

doi: 10.1002/ijc.24640